Search for European Projects

... million deaths a year worldwide. Thus the prediction of septic shock and stratification of high risk patients is still an unmet medical need.The novel bioreactive Adrenomedullin (bio-ADM) assay of Sphingotec is the first unprecedented analytical assay which stratified in a pilot study sepsis patients who have the risk to die from a septic shock with very high confidentiality. Thus adequate measur ...